Mylan Claims Fall In IP Suit Over Generic Azilect
A New Jersey federal judge on Tuesday tossed generics maker Mylan Inc.'s inequitable conduct defenses in a patent infringement suit brought by Teva Pharmaceutical Industries Ltd. over efforts to make a...To view the full article, register now.
Already a subscriber? Click here to view full article